daunorubicin has been researched along with Cancer of Gastrointestinal Tract in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, M; Kato, R; Miyagishima, T; Muranaka, T; Oda, H; Sawada, K; Sogabe, S; Takahashi, K; Takasaka, T; Umemura, M | 1 |
Hinderer, H; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
Fujita, H; Hattori, M; Kimura, K; Ogawa, M; Shimoyama, T; Taguchi, T; Wakui, A | 1 |
3 other study(ies) available for daunorubicin and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
[Case report; myeloid sarcoma with systemic lymphadenopathy, skin and gastrointestinal infiltration].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Gastrointestinal Neoplasms; Humans; Lymphatic Diseases; Male; Neoplasm Invasiveness; Sarcoma, Myeloid; Skin Neoplasms | 2014 |
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.
Topics: Antineoplastic Agents; Autoradiography; Breast Neoplasms; Cell Count; Cell Division; Culture Techniques; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Nucleic Acids; Ovarian Neoplasms; Procarbazine; Uridine | 1975 |
[A phase I trial of idarubicin by oral administration].
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Idarubicin; Male; Middle Aged; Uterine Neoplasms | 1987 |